Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Synchronous uterine adenocarcinoma and leiomyosarcoma: A rare case report causing a clinical conundrum.

Crean KK, Huang EC, Alvarez EA.

Int J Surg Case Rep. 2016;22:32-4. doi: 10.1016/j.ijscr.2016.03.005. Epub 2016 Mar 11.

2.

Alcohol Abuse Decreases Pelvic Control and Survival in Cervical Cancer: An Opportunity of Lifestyle Intervention for Outcome Improvement.

Mayadev J, Li CS, Lim J, Valicenti R, Alvarez EA.

Am J Clin Oncol. 2017 Oct;40(5):451-457. doi: 10.1097/COC.0000000000000187.

3.

Use of psychosocial services increases after a social worker-mediated intervention in gynecology oncology patients.

Abbott Y, Shah NR, Ward KK, McHale MT, Alvarez EA, Saenz CC, Plaxe SC.

Health Soc Work. 2013 May;38(2):113-21.

PMID:
23865288
4.

Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study.

Alvarez EA, Brady WE, Walker JL, Rotmensch J, Zhou XC, Kendrick JE, Yamada SD, Schilder JM, Cohn DE, Harrison CR, Moore KN, Aghajanian C.

Gynecol Oncol. 2013 Apr;129(1):22-7. doi: 10.1016/j.ygyno.2012.12.022. Epub 2012 Dec 20.

PMID:
23262204
5.

Changing demographics of cervical cancer in the United States (1973-2008).

Ward KK, Shah NR, Saenz CC, McHale MT, Alvarez EA, Plaxe SC.

Gynecol Oncol. 2012 Sep;126(3):330-3. doi: 10.1016/j.ygyno.2012.05.035. Epub 2012 Jun 2.

PMID:
22668881
6.

Cardiovascular disease is the leading cause of death among endometrial cancer patients.

Ward KK, Shah NR, Saenz CC, McHale MT, Alvarez EA, Plaxe SC.

Gynecol Oncol. 2012 Aug;126(2):176-9. doi: 10.1016/j.ygyno.2012.04.013. Epub 2012 Apr 13.

PMID:
22507532
7.

Combined Src and ER blockade impairs human breast cancer proliferation in vitro and in vivo.

Chen Y, Alvarez EA, Azzam D, Wander SA, Guggisberg N, Jordà M, Ju Z, Hennessy BT, Slingerland JM.

Breast Cancer Res Treat. 2011 Jul;128(1):69-78. doi: 10.1007/s10549-010-1024-7. Epub 2010 Jul 29.

PMID:
20669046
8.

A phase I study of docetaxel as a radio-sensitizer for locally advanced squamous cell cervical cancer.

Alvarez EA, Wolfson AH, Pearson JM, Crisp MP, Mendez LE, Lambrou NC, Lucci JA 3rd.

Gynecol Oncol. 2009 May;113(2):195-9. doi: 10.1016/j.ygyno.2008.12.033. Epub 2009 Feb 28.

PMID:
19251309

Supplemental Content

Loading ...
Support Center